Vijaya Diagnostic Centre Share Price

Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 4 weeks 2 days ago

Healthcare Services company Vijaya Diagnostic Centre announced Q4FY26 & FY26 results Financial Highlights: Revenue from Operations for Q4FY26 was Rs 2,193.8 million, representing a YoY growth of 26.6% compared to Rs 1,732.4 million in Q4FY25. For the full year FY26, Revenue from Operations reached Rs 8,142.0 million, an increase of 19.5% YoY from Rs 6,813.9 million in FY25. EBITDA for Q4FY26 stood at Rs 955.2 million, showing a growth of 38.7% YoY over Rs 688.6 million in Q4FY25. Annual EBITDA for FY26 was Rs 3,369.4 million, reflecting a YoY increase of 23.3% from Rs 2,732.2 million. The EBITDA margin for Q4FY26 improved to 43.5% from 39.8% in Q4FY25, while the annual EBITDA margin for FY26 stood at 41.4%. Profit after Tax (PAT) for Q4FY26 was Rs 479.3 million, growing by 37.5% YoY from Rs 348.6 million. For the full year FY26, Profit after Tax (PAT) was Rs 1,729.8 million, representing a growth of 20.3% YoY compared to Rs 1,437.9 million in FY25. The PAT margin for Q4FY26 was 21.8% compared to 20.1% in Q4FY25. Business Highlights Operational Performance: Total tests conducted in Q4FY26 reached 4.49 million, an 18.5% YoY growth. For the full year FY26, total tests were 16.92 million. Footfall: Total footfall for Q4FY26 grew 15.8% YoY to 1.21 million. Annual footfall for FY26 stood at 4.68 million. Realization: Average realization per footfall reached Rs 1,808 in Q4FY26, representing a 9.3% YoY increase. Average realization per test for the quarter was Rs 488. Segment Performance: Growth was broad-based, driven by strong momentum in both pathology and radiology segments. Wellness Share: The wellness segment's share of revenue stood at 15.6% in Q4FY26 compared to 15.0% in Q4FY25. Strategic Expansion: The company reported its highest-ever quarterly revenue of Rs 219 crore in Q4FY26. Hub Performance: The Khammam and Nandyal hubs achieved break-even within two quarters of operation. The Ambegaon hub in Pune achieved break-even within one year of launch. Network Growth: The company's network of centres has doubled over the last five years. As of FY26, the operational network spans 160+ diagnostic centres and 30 reference laboratories across 27 cities and towns. Future Outlook: For FY27, the company intends to add 4–5 hubs and 10–12 spokes. It is also setting up a fully automated laboratory with track infrastructure at Panjagutta, Hyderabad. Technology Initiatives: Vijaya is actively deploying AI-led solutions to improve diagnostic accuracy and workflow efficiency, currently across urology and dental diagnostics. Suprita Reddy, MD & CEO said: “FY26 was a landmark year for Vijaya, as revenues crossed Rs 800 crore, translating into a 16.5% CAGR over the five years since listing, outperforming our long-term guidance of 15%. EBITDA margins also remained ahead of our 40% guidance, reflecting disciplined execution. Over the same period, our network of centres doubled. Q4FY26 was particularly strong, with Vijaya reporting its highest-ever quarterly revenue of Rs 219 crore. Revenue grew ~26.5% YoY, supported by ~18.5% volume growth across the network. Growth was broad-based, driven by strong momentum in both pathology and radiology segments, supported by network expansion and improving brand acceptance in newer markets. Our expansion strategy continues to deliver encouraging outcomes. The Khammam and Nandyal hubs achieved break-even within two quarters, while the Ambegaon hub in Pune achieved break-even within one year of launch, reinforcing our confidence in scaling newer geographies efficiently.” Result PDF

• Trendlyne
• 4 weeks 2 days ago

Healthcare Services company Vijaya Diagnostic Centre announced Q3FY26 results Revenue from operations: Rs 2,052.1 million against Rs 1,689.8 million during Q3FY25, change 21%. EBITDA: Rs 860.5 million against Rs 671.3 million during Q3FY25, change 28%. EBITDA Margin: 41.9% for Q3FY26. PAT: Rs 431.8 million against Rs 353 million during Q3FY25, change 22%. PAT Margin: 21% for Q3FY26. Suprita Reddy, MD & CEO, said: “Vijaya reported a robust Q3FY26 delivering a strong revenue growth of ~21.4%, supported by volume growth of nearly ~15%. Importantly, revenues also surpassed Q2 in absolute terms, a notable achievement considering Q3 is traditionally impacted by festive and seasonal softness. During the quarter, we expanded our network with the successful commissioning of new hub centres in Phoolbagan and Diamond Harbour, increasing our hub footprint in West Bengal to seven. Additionally, two new hub centres were commissioned in our core markets of Khammam and Nandyal. I am pleased to share that both hub centres launched in Q1FY26 in West Bengal—Krishnanagar and Barasat—achieved break-even within just three quarters of commencing operations, well ahead of the projected timeline of one year. We have also strengthened our leadership team with the addition of a CFO, CTO, and COO, along with key hires across our clinical and corporate functions. Moving forward, our key areas of focus would be stabilisation of the newly launched hubs, commissioning multiple spokes across our network, continued investment in latest technology to provide better customer experience and building strong brand equities in these new geographies.” Result PDF

• Trendlyne
• 3 months 3 weeks ago